Metastatic Breast Cancer & the TUGETHER Clinical Trial: What You Need to Know

Metastatic Breast Cancer & the TUGETHER Clinical Trial: What You Need to Know

Metastatic Breast Cancer & the TUGETHER Clinical Trial: What You Need to Know

Maria Bodnar is a retired nurse, living in Victoria, Australia, with her husband. In 2013, Maria went in for her routine Breast Screen test, and the following day she received a call from one of the nurses asking her to come in so they could review her results, and Maria knew it was breast cancer.

Maria is a participant in the TUGETHER clinical trial, which aims to find out if adding tucatinib and pembrolizumab to the usual treatment given to people with advanced (metastatic) HER2-positive breast cancer slows down the growth of the cancer. We spoke to Maria about her diagnosis and her decision to participate in a clinical trial.

Like this episode? ⁠⁠Follow Breast Cancer Trials on Social Media:

Guest: Maria Bodnar, Trial Participant

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about clinical trials research.

Find out more: www.breastcancertrials.org.au

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(164)

Could Patients with Breast Cancer Safely Skip Radiation & the Potential Side Effects? Inside the ROSALIE Clinical Trial

Could Patients with Breast Cancer Safely Skip Radiation & the Potential Side Effects? Inside the ROSALIE Clinical Trial

Could Patients with Breast Cancer Safely Skip Radiation & the Potential Side Effects? Inside the ROSALIE Clinical TrialCould skipping radiation after breast-conserving surgery be safe for some patient...

6 Feb 6min

Neoadjuvant Now: What's Next in Pre-Surgical Breast Cancer Treatment?

Neoadjuvant Now: What's Next in Pre-Surgical Breast Cancer Treatment?

Neoadjuvant Now: What's Next in Pre-Surgical Breast Cancer Treatment?More and more breast cancer patients are now receiving treatment before surgery - but what’s next for this approach? In this episod...

7 Nov 20259min

Next Gen Oncology: Insights for Trainees and Early-Career Clinicians

Next Gen Oncology: Insights for Trainees and Early-Career Clinicians

Next Gen Oncology: Insights for Trainees and Early-Career CliniciansAre you a trainee or early career professional in oncology looking to connect, learn, and grow? In this episode, we highlight the Tr...

6 Nov 20258min

Caring for the Caregivers: Preventing Burnout in Oncology

Caring for the Caregivers: Preventing Burnout in Oncology

Caring for the Caregivers: Preventing Burnout in OncologyWhat happens when the people caring for everyone else are running on empty? In this episode, we sit down with London-based Professor of psycho-...

6 Nov 202521min

Intimacy and Insight: Sexual Health After Breast Cancer

Intimacy and Insight: Sexual Health After Breast Cancer

Intimacy and Insight: Sexual Health After Breast CancerSexual health after breast cancer is a topic too often left in the shadows - yet it profoundly affects quality of life both during and post-diagn...

29 Okt 202510min

Choosing Your Path & Navigating Difficult Treatment Decisions

Choosing Your Path & Navigating Difficult Treatment Decisions

Choosing Your Path & Navigating Difficult Treatment DecisionsWhat happens when patients say ‘no’ to recommended treatments? The search for alternatives can be confronting for both patients and clinici...

28 Okt 202518min

Lotjpa Yapaneyepuk (Talk Together): Bridging Communities and Cancer Research

Lotjpa Yapaneyepuk (Talk Together): Bridging Communities and Cancer Research

Lotjpa Yapaneyepuk (Talk Together): Bridging Communities and Cancer Research Access to clinical trials isn't equal, and for Aboriginal and Torres Strait Islander peoples in Regional Victoria, barriers...

15 Okt 202519min

4CASTING the Future: Innovations in Triple Negative Breast Cancer

4CASTING the Future: Innovations in Triple Negative Breast Cancer

4CASTING the Future: Innovations in Triple Negative Breast Cancer Triple negative breast cancer remains one of the most challenging types to treat because it lacks the common treatment targets, grows ...

8 Okt 202510min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
inga-beiga-morsor
rss-vuxna-pa-latsas
sexnoveller-deluxe
not-fanny-anymore
rss-viktmedicinpodden
sova-med-dan-horning
angestpodden
johannes-hansen-podcast
sa-in-i-sjalen
medicinvetarna
tyngre-radio
rss-vad-hander-bror
rss-autismandan
smartare-fitness-podden
rss-sjalsligt-avkladd
dodsdomar
rss-basta-livet
rss-pappahjartat